Nutraplus India Limited SHARE PRICE [LIVE]

BSE: INE230G01020   NSE: NUTRA   SECTOR: Pharma

OPEN YOUR FREE DEMAT ACCOUNT AND START TRADING SEAMLESSLY
Already an existing customer? - Login Now!
NSE
N/A
Change:
BSE
N/A
Change:
NSE
BSE Click here to view BSE data
Open:
High:
Low:
MKT Cap:
52-wk High:
52-wk Low:
Prev close:
P/E:
Div yield:

Fundamental analysis

Quality
Valuation
0 250 500 750 1 000
Financial trend

What is not working for the company?

What is working for the company?

Stock
Sector
Sensex
Name Mar 21 Dec 20

Similar Stocks

Return Calculator

This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.

If I had made LUMPSUM investment of ₹ 1,00,000

in Nutraplus India Limited

Months ago

My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %

NUTRA News

Frequently Asked Questions

Can I buy Nutraplus India Limited (NUTRA) shares?

Yes, You can buy Nutraplus India Limited (NUTRA) shares by opening a Demat account with Angel One.

How do I buy Nutraplus India Limited (NUTRA) from Angel One?

Nutraplus India Limited (NUTRA) share can be brought through the following modes:
  1. Direct investment: You can buy Nutraplus India Limited (NUTRA) shares by opening a Demat account with Angel One.
  2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Nutraplus India Limited (NUTRA) shares.

In which sector do Nutraplus India Limited (NUTRA) belong?

Nutraplus India Limited (NUTRA) belongs to Pharma.

About NUTRA

Today's live share price for Nutraplus India Limited is NSE: N/A, BSE: N/A with a current market capitalization of .

Nutraplus Products (India) Limited was originally incorporated as a private limited company on 6 Feb.'90. It was subsequently converted into a public limited company with effect from 13 Jun.'92. The company implemented a project for the manufacture of veterinary bulk drugs namely dimentridazole (DMZ) and dinitolmide (DOT) at Tarapur, Maharashtra. Initially, the company set up manufacturing facilities for the manufacture of methyl nitro imidazole, an intermediate of DMZ, with an installed capacity of 240 tpa, at a cost of Rs 123.66 lac, for which was sanctioned a term loan of Rs 60 lac from the Maharashtra State Financial Corporation (MSFC). The company has set-up new product Roxarsone from Jan'96 and also set up production of Dinitolmide. During 2001-02 the company set up a production of newly developed Bulk Drugs Metformin HCL. It is also planning to foray in the manufacture of life saving drugs.

Read more